Northwestern Medicine Interstitial Lung Disease and Pulmonary Fibrosis Program
We are dedicated to caring for people with complex inflammatory and fibrotic lung diseases. We strive to provide compassionate and cutting-edge care to help you reach better physical, mental and social health.
Our Program Goals
- Diagnose and treat interstitial lung disease.
- Support you and your caregivers throughout the interstitial lung disease journey.
- Allow for the opportunity to participate in clinical trials for treatments that are not yet widely available.
- Teach you about interstitial lung disease, its symptoms, disease progression, and characteristics.
- If needed, refer you to the Northwestern Medicine Lung Transplant Team.
Common Diseases We Treat
- Pulmonary fibrosis, both idiopathic and familial
- Short telomere syndrome
- Connective tissue disease interstitial lung disease
- Scleroderma
- Systemic sclerosis
- Rheumatoid arthritis
- Sjogren’s syndrome
- Anti-synthetase syndrome
- Dermatomyositis
- Polymyositis
- Systemic lupus erythematosus
- Vasculitis
- Non-specific interstitial pneumonitis (NSIP)
- Lymphocytic interstitial pneumonitis (LIP)
- Cryptogenic organizing pneumonitis (COP)
- Smoking-related interstitial lung disease
- Exposure-related interstitial lung disease
- Hypersensitivity Pneumonitis
- Occupational Lung Disease
- Cystic lung disease
- Sarcoidosis
- Pulmonary alveolar proteinosis
- Eosinophilic pneumonias
- COVID-19-related lung disease
Meet the Teams
The Interstitial Disease and Pulmonary Fibrosis Program Teams provide comprehensive and advanced care to patients with interstitial lung disease (ILD) and pulmonary fibrosis from all causes.